Mouse erythroleukemia cells
Gopalakrishnan, T.V.; Anderson, W.F.
Methods in Enzymology 58: 506-511
1979
ISSN/ISBN: 0076-6879 PMID: 284164 Document Number: 141549
Document emailed within 1 workday
Related Documents
Eliopoulos, A.; Kerr, D.J.; Spandidos, D.A. 1991: The effect of doxorubicin, daunorubicin and 4'-epidoxorubicin on the exogenous c-myc promoter in mouse erythroleukemia cells Anticancer Research 11(6): 2153-2157Jing, Y.; Waxman, S. 1995: Structural requirements for differentiation-induction and growth-inhibition of mouse erythroleukemia cells by isoflavones Anticancer Research 15(4): 1147-1152
Waxman, S.; Scher, B.M.; Hellinger, N.; Scher, W. 1990: Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide Cancer Research 50(13): 3878-3887
Zavodny, P.J.; Roginski, R.S.; Skoultchi, A.I. 1983: Regulated expression of human globin genes and flanking DNA in mouse erythroleukemia--human cell hybrids Progress in Clinical and Biological Research 134: 53-62
Sato, T.; Friend, C.; De Harven, E. 1971: Ultrastructural changes in Friend erythroleukemia cells treated with dimethyl sulfoxide Cancer Research 31(10): 1402-1417
Covell, A.M.; Einspahr, D.E.; Skikne, B.S.; Cook, J.D. 1987: Specific binding of acidic isoferritins to erythroleukemia K562 cells Journal of Laboratory and Clinical Medicine 110(6): 784-790
Tojo, A.; Fukamachi, H.; Saito, T.; Kasuga, M.; Urabe, A.; Takaku, F. 1988: Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment Cancer Research 48(7): 1818-1822
Haspel, H.C.; Ren, Y.F.; Watanabe, K.A.; Sonenberg, M.; Corin, R.E. 1984: Cytocidal effect of gossypol on cultured murine erythroleukemia cells is prevented by serum protein Journal of Pharmacology and Experimental Therapeutics 229(1): 218-225
Han, Z.C.; Maurer, A.M.; Bellucci, S.; Wan, H.Y.; Kroviarski, Y.; Bertrand, O.; Caen, J.P. 1992: Inhibitory effect of platelet factor 4 (PF4) on the growth of human erythroleukemia cells: proposed mechanism of action of PF4 Journal of Laboratory and Clinical Medicine 120(4): 645-660
Fibach, E.; Yamasaki, H.; Weinstein, I.B.; Marks, P.A.; Rifkind, R.A. 1978: Heterogeneity of murine erythroleukemia cells with respect to tumor promoter-mediated inhibition of cell differentiation Cancer Research 38(11 Part 1): 3685-3688
Honma, Y.; Onozuka, Y.; Okabe-Kado, J.; Kasukabe, T.; Hozumi, M. 1991: Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity Cancer Research 51(17): 4535-4538
Feoktistov, I.; Murray, J.J.; Biaggioni, I. 1994: Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells Molecular Pharmacology 45(6): 1160-1167
Fuchs, O. 1997: Effects of intracellular chelatable iron and oxidative stress on transcription of classical cellular glutathione peroxidase gene in murine erythroleukemia cells Neoplasma 44(3): 184-191
McKernan, R.M.; Strickland, W.R.; Insel, P.A. 1988: Selective blockade and recovery of cell surface alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells. Studies with the irreversible antagonist benextramine Molecular Pharmacology 33(1): 51-57
Kalinina, E.V.; Novichkova, M.D.; Shcherbak, N.P.; Saprin, A.N. 2000: Inhibitory effect of progesterone P1-1 on glutathione-s-transferase and its antiproliferative effect on human erythroleukemia K562 cells Voprosy Onkologii 46(1): 68-73
Mamalaki, A.; Moschonas, N. 1989: Transcriptional regulatory factors may control the relative expression of human alpha 1 and alpha 2-globin genes in erythroleukemia cells Progress in Clinical and Biological Research 316a: 335-342
Kurimura, T.; Kimura, M.; Eizuru, Y.; Minamishima, Y. 1977: Electron microscopic studies of the replication of mouse cytomegalovirus in mouse embryo cells Acta Virologica 21(6): 491-494
Yigit, R.; Fisher, J.W. 1983: Activation of erythroid colony forming cells (CFU-E) by cyclic AMP in adult mouse bone marrow and fetal mouse liver cultures Haematologica 68(3): 301-311
Reynolds, N.J.; Fisher, G.J.; Griffiths, C.E.; Tavakkol, A.; Talwar, H.S.; Rowse, P.E.; Hamilton, T.A.; Voorhees, J.J. 1993: Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo Journal of Pharmacology and Experimental Therapeutics 266(3): 1636-1642
Moyes, R.B.; Kirch, H.; DeLoach, J.R. 1996: Enhanced biological activity of human recombinant interleukin 2 coupled to mouse red blood cells as evaluated using the mouse Meth a sarcoma model Biotechnology and Applied Biochemistry 23(1): 29-36